Soluble guanylate cyclase modulators—a novel therapeutic approach for diabetic kidney disease

Diabetic kidney disease (DKD) is a common complication, affecting approximately 40% of patients with diabetes and imposing substantial health and economic burdens worldwide. As DKD prevalence rises, existing treatments remain limited in efficacy, necessitating innovative therapeutic strategies. Solu...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuqing Xu, Xuan Wu, Mingpai Ge, Kunhan Liang, Jixin Xing, Peng Zhang, Huilin Li, Zhiyong Guo, Xiaobin Mei
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2025-12-01
Edice:	Renal Failure
Témata:	sGC modulators diabetic kidney disease proteinuria efficacy safety
On-line přístup:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2595385
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!